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Abstract
Mycobacterium indicus pranii (MIP), also known as Mw, is a saprophytic, non-pathogenic strain of Mycobacterium and is
commercially available as a heat-killed vaccine for leprosy and recently tuberculosis (TB) as part of MDT. In this study we
provide evidence that cell-free supernatant collected from original MIP suspension induces rapid and enhanced apoptosis in
mouse peritoneal macrophages in vitro. It is demonstrated that the MIP cell-free supernatant induced apoptosis is
mitochondria-mediated and caspase independent and involves mitochondrial translocation of Bax and subsequent release
of AIF and cytochrome c from the mitochondria. Experiments with pharmacological inhibitors suggest a possible role of PKC
in mitochondria-mediated apoptosis of macrophages.
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Introduction
Mycobacterium indicus pranii (MIP) is a non-pathogenic, sapro-
phytic and cultivable strain of Mycobacterium and belongs to
Runyon group IV based on its growth and biochemical
characteristics [1]. A vaccine against leprosy based on MIP is
approved for human use, where it has resulted in modest clinical
improvement, accelerated bacillary clearance, and increased
immune responses to Mycobacterium leprae antigens, thereby
shortening the full recovery time of the patients [2,3,4]. Recently
MIP has emerged as a broad spectrum vaccine candidate as it
shares antigens not only with M. leprae but also with M. tuberculosis.
Recently conducted clinical trials involving approximately 30,000
human subjects have shown that vaccination with heat killed MIP
induced protection against TB and also resulted in early sputum
conversion in TB patients [5]. Studies with animal models have
shown that MIP, commercially available as ‘‘Immuvac’’ confers
protection against M. tuberculosis infection in both BCG responder
and non-responder genetic strains of mice [6,7]. The ongoing
polyphasic molecular and biochemical studies have assigned a
discrete & unique phylogenetic position to MIP [8]. MIP does not
cause infection in any of the animal models in which it has been
tested inspite of its close resemblance to Mycobacterium avium
complex; based on the initial results of the clinical trials, it is under
extensive trial for a number of serious diseases including cancer
[7,9-12]. Owing to these unique immunologic properties, MIP
appears to be a promising & safe philanthropic vaccine candidate.
During the early stages of infection with intracellular pathogens
like M. tuberculosis, the extent of bacterial survival and proliferation
is mainly determined by the efficacy of the innate immune
response with macrophages as the main effector cells [13,14]. To
look for immunomodulatory properties of heat killed MIP, effect
of MIP on murine peritoneal macrophages was investigated in vitro.
Macrophages were treated with increasing volumes of the original
commercial suspension. While lower volumes led to macrophage
activation (unpublished data), rapid cell death of macrophages was
observed at higher volumes. The experiments with inserts revealed
that induced cell death of macrophages was independent of the
direct contact between the heat-killed bacterium & the macro-
phage cell surface (data not shown). To resolve the case further,
the study was conducted using either the cell-free supernatant (as
defined in ‘materials and methods’ section) or washed cell pellet
alone. While the washed cell pellet of heat-killed MIP led to
differential activation of macrophages (unpublished data), inter-
estingly, the cell-free supernatant was found to induce rapid cell
death of mouse peritoneal macrophages in vitro. Based upon a
number of independent parameters we present evidence that MIP
cell-free supernatant induces programmed cell death of mouse
peritoneal macrophages in vitro which is caspase independent and
involves induction of the mitochondrial pathway. We also
demonstrate that at lower doses the cell free supernatant leads to
a significant downregulation of LPS-induced proinflammatory
cytokine expression in peritoneal macrophages in vitro. We propose
that the strong apoptogenic activity of MIP supernatant may
reduce the potency of MIP as a vaccine & may in part be
responsible for the early side-effects at the site of injection.
Materials and Methods
Ethics Statement
The studies presented in this manuscript were approved by the
Scrutiny Committee of the School of Biotechnology, Banaras
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Project 1987/dt. 31-11-1987.
Mice
Inbred strains of Balb/c mice of either sex at 8–10 weeks of age
were used for obtaining peritoneal macrophages.
Cell cultures and reagents
Macrophages were cultured in RPMI 1640 medium supple-
mented with heat-inactivated fetal calf serum (10%), Penicillin
(100 U/ml), Streptomycin (100 U/ml) and Gentamycin (20 ug/
ml) at 37uC in humidified air containing 5% CO2. Heat-killed
MIP suspension, thiomersal were obtained from Cadila Pharma-
ceuticals, India. Proteinase K, Polymixin B, Medium RPMI 1640,
TRI-reagent, Staurosporin, Rottlerin, H7, Annexin V-Cy3
APOAC apoptosis detection kit, caspase-3 & caspase-8 fluorimet-
ric assay kits and most of the other reagents, until mentioned
otherwise, were obtained from Sigma-Aldrich Chemicals, St
Louis, MO, USA. Fetal calf serum was purchased from Biological
Industries, Israel. Broad spectrum caspase inhibitor Z-VAD-fmk,
caspase-3 inhibitor Ac-DEVD-CHO and caspase 8 inhibitor Z-
IETD-fmk were purchased from Imgenex Co, San Diego, CA,
USA. Mitocapture Apoptosis detection kit and Nucleosome
ELISA kit were from Calbiochem, La Jolla, CA, USA. Polyclonal
antibodies against caspase-3 & 8, Bax, PARP, PKC d, Actin, AIF
and cytochrome c, FITC conjugated anti-Bax, TRITC conjugated
anti-AIF were obtained from Santa Cruz Biotechnology Inc, CA,
USA. All the reagents were endotoxin-free as determined by the
Limulus amoebocyte lysate assay (sensitivity limit, 0.1 ng/ml).
Preparation of MIP cell-free supernatant
Original heat-killed MIP suspension contains 5610
9 MIP cells/
ml suspended in 0.9% w/v sodium chloride & 0.01% w/v
thiomersal. The original suspension was centrifuged at 10,000 rpm
and the cell-free supernatant & pellet were carefully separated
under strictly sterile conditions. The pellet containing MIP cells
was washed and resuspended to the original volume in sterile PBS.
Mouse peritoneal macrophages were treated either with different
volumes (60–100 ul/ml/10
6 cells) of the cell-free supernatant
(henceforth termed MIP supernatant) or with resuspended MIP
cell pellet for different time intervals. Doses mentioned as sub-
threshold are #40 ul/ml/10
6 cells/well.
Macrophage Isolation and cytotoxicity assay
Macrophage monolayers were prepared as described previously
[15]. Peritoneal exudate cells (PECs) were harvested from the
healthy, inbred strain of Balb/c mice (8–10 weeks old, 20–22gms)
using chilled serum-free RPMI 1640 medium and plated in the
wells of 24 well plate (Nunc, Denmark). After 2 hr incubation at
37uC in an atmosphere of 5% CO2 in a CO2 incubator, the non-
adherent cells were removed by washing with warm serum-free
medium and the adherent cells were further incubated in complete
medium overnight to form macrophage monolayer. More than
95% of the adherent cell population was macrophages as
determined by morphology and non-specific esterase staining.
Cytotoxic activity of MIP supernatant was measured by MTT
(4, 5-dimethylthiazol-2-yl-2, 5-diphenyl tetrazolium bromide)
assay [16]. Briefly peritoneal macrophages (10
6 cells/well) were
cultured in 24 well culture plates in 1 ml RPMI 1640 medium.
After overnight culture, the cells were washed and then treated
with various doses of MIP supernatant for different time intervals
in fresh medium. To exclude the possibility of cytotoxicity by MIP
supernatant due to endotoxin contamination, macrophages were
incubated with polymyxin B (20 mg/ml)-treated MIP supernatant
for 8 hr. After completion of treatment, 50 ml of 5 mg/ml MTT
solution was added to the monolayers and incubated for 4 hr at
37uC. The MTT reaction was terminated by the addition of 0.04N
HCl in isopropanol. The MTT formazan formed was measured
spectrophotometrically (540 nm) using an EMax Spectrophotom-
eter (Molecular Devices, Sunnyvale, CA, USA).
The % cytotoxicity was calculated by formula:
% Cytotoxicity~
C{T
C
|100
Where C= absorbance ‘control’ represents macrophages incu-
bated in medium alone and T= absorbance ‘experimental’
represents macrophages treated with MIP supernatant.
Immunofluorescence staining
Peritoneal macrophage monolayers on cover glass were treated
with MIP supernatant for 4–6 hr. To evaluate nuclear morphol-
ogy, the cells on cover glass were fixed with 4% paraformaldehyde,
stained with DAPI (10 mg/ml) in phosphate-buffered saline (PBS)
for 10 min, and then observed under fluorescence microscope
(Olympus BX61, Olympus optical Co. Ltd. Tokyo, Japan).
For staining Bax or AIF, macrophage monolayers on cover glass
were treated with MIP supernatant for 1–4 hr. After treatment,
macrophage monolayers were washed with warm incomplete
medium. The cells were then fixed in 4% paraformaldehyde for
10 min at room temperature, washed (three times) in PBS and
permeabilized with 0.1% Triton X-100 for 5 min at room
temperature. Cells were washed twice in PBS and incubated in
PBS containing 1% BSA for 60 min, blocking the nonspecific
binding sites. Subsequently, the cells were incubated with anti-
Bax-FITC or anti-AIF-TRITC antibody overnight at 4uC in dark,
washed with chilled PBS containing 0.05% Tween 20 (three
times), observed and photographed with Olympus fluorescence
microscope. Non-specific fluorescence staining was ruled out using
non-specific isotypic antibodies (data not shown).
Apoptosis Assays
Annexin V-Cy3 and Mitocapture Apoptosis detection kits were
used to detect apoptosis in macrophages under fluorescence
microscope. For Annexin V-Cy3 staining, macrophage monolay-
ers on cover-glass were incubated for 4 hr with MIP supernatant
(100 ul/ml/10
6 cells). The cells were washed twice with PBS and
then with 16binding buffer (3 times), stained with Double Label
Staining Solution (AnnCy3+6-CFDA) as per manufacturer’s
instructions. After 10 min, the monolayers were washed with 16
binding buffer (5 times) and observed under fluorescence
microscope. The green fluorescing cells were scored as healthy
cells, whereas green cells with red periphery were considered
apoptotic. Untreated cells served as control.
The MitoCapture Apoptosis Detection Kit was used for
detection of mitochondrial membrane depolarization (Dym).
Untreated or MIP supernatant treated macrophage monolayers
were incubated with 1 mg/ml of Mitocapture cationic dye at 37uC
for 20 min. Cells were photographed using fluorescence micro-
scope with excitation wavelengths of 500 and 570 nm. Cells
exhibiting green fluorescence indicating lowering of mitochondrial
transmembrane potential were counted as apoptotic cells. Cells
with red specks for mitochondria indicate presence of J-aggregates,
and thus were considered as normal cells. At least 5 independent
spots were observed for each slide.
MIP Induced Macrophage Apoptosis
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DNA fragmentation
The Nucleosome ELISA Kit was used to quantify free
oligonucleosome units resulting due to MIP supernatant-induced
DNA fragmentation in macrophages as recommended by the
manufacturer. Briefly, macrophage monolayers treated with MIP
supernatant were washed and lysed. The lysates were used to
measure free oligonucleosome units by antigen capture ELISA.
The optical density at 450 nm was read in EMax Spectropho-
tometer (Molecular Devices, Sunnyvale, CA, USA). Triplicate
wells were assayed for each condition. Free oligonucleosome DNA
fragments were quantified according to the manufacturer’s
instruction manual.
Caspase activity assays
The caspase-3 and caspase-8 activities were determined by
using fluorimetric assay kits. Briefly, macrophages were pretreat-
ed either with caspase-8 inhibitor Z-IETD-FMK (50 mM) or
caspase-3 inhibitor Ac-DEVD-CHO (100 mM) for an hour in
incomplete medium. The medium was replaced and macrophag-
es were incubated in fresh complete medium with MIP
supernatant for 2 hr. The cells were then lysed as per the
instructions provided. 5 ml of cell lysates were added to the wells
of a 96 well flat bottom plate. For blank 5 ml of 1X assay buffer
was used. To some wells 200 mM of caspase-3 or caspase-8
inhibitor was added. 200 ml of reaction mixture was then added
gently to each well. Plate was covered for 12 hr in dark (kept at
280uC) and read at 360 nm excitation and 460 nm emission at
37uC in a Microplate Fluorescence Reader (FLx 800, Bio-Tek
Instruments, Inc., USA).
Preparation of cell lysates and immunoblotting
The macrophages with or without treatment were washed with
ice cold PBS containing 1 mM Na3VO4, then lysed in 50 mlo f
RIPA lysis buffer supplemented with protease inhibitor cocktail for
20 min at 4uC. The lysates were centrifuged (13,000 g at 4uC) for
15 min and the supernatant (containing Triton X-100 soluble
proteins) were separated on 10% SDS-polyacrylamide gels at 20
mA. The separated proteins were transferred onto nitrocellulose
membrane (45 min. at 200 mA) using Bio-Rad mini transblotter
and immunoblotted with primary antibody, incubated with
secondary antibody conjugated with horseradish peroxidase and
visualized by the chemiluminescence Western blotting kit (Santa
Cruz Biotechnology, CA, USA). Cytosolic extract (excluding
nuclei and mitochondria) was prepared using a previously
reported method and used for western blotting against cytochrome
c antibody. For nuclear translocation studies, purified nuclei were
isolated using NE-PER nuclei extraction kit (Pierce, Rockford, IL,
USA). To monitor equal loading of protein, western blot analysis
using antibody directed against Actin was done for each
experiment as shown in lower panels.
Enzyme Linked Immunosorbent Assay (ELISA)
Macrophage monolayers were treated with specified doses of
MIP supernatant/& other reagents as mentioned, supernatant was
collected & ELISA was performed as per manufacturer’s
instruction.
MALDI-Tof analysis of the ,46 kDa supernatant band
MIP cell-free supernatant was lyophilized and re-suspended in
sterile PBS & run on SDS-PAGE. The protein band visible at
,46 kDa was cut & sent for MALDI-Tof analysis which was
performed by ILS Bioservices Pvt Ltd, Gurgaon, India.
Statistical Analysis
The statistical significance of difference between the test groups
was analyzed by student’s t-test (two tailed). p-value of less than
0.05 is considered significant. The error bars of the values
represent 95% confidence interval.
Results
MIP cell-free supernatant induces apoptosis of peritoneal
macrophages in vitro
MIP cell-free supernatant resulted in significant cell death of
peritoneal macrophages. The percent cytotoxicity of MIP
supernatant was quantitatively determined by MTT assay. It
was observed that 60–70 ul of MIP supernatant induced cell death
in ,40–45% of macrophages by 8 hr of incubation. However,
100 ul/ml of MIP supernatant resulted into about 70–75% cell
death of macrophages in the same time interval (Fig. 1a). To
examine if the mode of induced cell death was apoptosis,
macrophage monolayers were incubated with a range of
supernatant volumes and assessed for detection of Phosphatidyl-
serine exposure on the outer leaflet of the cell membrane by
annexin V binding. Significant levels of apoptosis were apparent
with as little as 60 ul/ml of MIP supernatant and continued to
increase through 100 ul/ml, the maximum dose examined
(Fig. 1b). The treatment of macrophage monolayers with MIP
supernatant resulted into DNA fragmentation in a dose dependent
fashion whereas chromatin condensation and nuclear fragmenta-
tion were also observed by DAPI staining at 6 hr of treatment
(Fig. 1c, d).
Proteomic analysis of MIP cell-free supernatant
Cell-free supernatant consistently showed a band of ,46 kDa
on SDS-PAGE (Fig. 1e). MALDI-TOF analysis of the band
resulted into a number of fragments which showed a significant
homology to Peptide Chain Release Factor 1 of bacterial origin.
Following three tryptic fragments showed partial identities to two
proteins, namely 1) a putative short chain dehydrogenase of
unknown function, and 2) RpoB protein, when BLASTed against
the Mycobacterium indicus pranii (taxid: 35617) database:
1). SQLQNKERAMQMLR
2). TYNYPQSRVTDHR
3). RTMVATGDRSAK
Interestingly, the first and the second fragments had domain hits
for prfA (Peptide Chain Release Factor 1) in the conserved
domains database (http://www.ncbi.nlm.nih.gov/Structure/cdd/
cdd.shtml).
MIP cell-free supernatant induced apoptosis is not due to
LPS contamination
To examine whether LPS contamination might be contributing
to apoptosis induction by MIP supernatant, supernatant was
incubated with polymyxin B before addition to macrophage
monolayers. The proapoptotic effect of supernatant was found to
be polymyxin B- resistant which indicated that LPS contamination
was not contributing to the apoptosis observed in cells exposed to
supernatant protein (Fig. 1a).
MIP cell-free supernatant induces cleavage of caspase 3,
PARP
Treatment of macrophages with MIP supernatant led to
activation of caspase 3. The estimation of caspase 3 activity was
based on the ability of the supernatant treated cell lysates to
hydrolyze the fluorogenic peptide substrate of caspase 3, acetyl-
MIP Induced Macrophage Apoptosis
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resulting in the release of the fluorescent 7-amino-4-methylcou-
marin (AMC) moiety which can be quantified. The expression of
cleaved active form of caspase 3 (p17) increased with time (Fig. 2a,
b). Cleavage of caspase 3 substrate PARP was also observed in
macrophages treated with MIP supernatant (Fig. 2b). On the other
hand MIP supernatant did not result in the activation of caspase 8.
MIP cell-free supernatant induced apoptosis is
mitochondria mediated
Treatment of macrophages with MIP supernatant led to
lowering of mitochondrial membrane potential (MMP) (Dym).
Changed MMP was observed in macrophages using Mitocapture
cationic dye. Macrophages showing green fluorescence suggest
cells with changed mitochondrial membrane potential, whereas
cells with normal mitochondria show red fluorescence. The
number of macrophages with altered mitochondrial membrane
potential significantly increased with time on treatment with MIP
supernatant. By 4 hr of treatment ,70% of cells showed green
fluorescence, and thus decreased Dym. The green and red
fluorescing cells observed under fluorescence microscope were
counted from at least five different spots and their mean is
expressed as % apoptotic cells. Pretreatment of macrophages with
either caspase-8 inhibitor Z-IETD-fmk or pan-caspase inhibitor
Z-VAD-fmk had no effect on the onset of mitochondrial
membrane potential (Dym) disruption induced by MIP superna-
tant (Fig. 2c).
MIP cell-free supernatant causes release of cytochrome c,
AIF from mitochondria and nuclear translocation of AIF
Mitochondria mediated apoptosis may involve the release of
cytochrome c and AIF from the mitochondria into the cytoplasm.
This possibility was tested by fractionating nuclei, cytoplasm and
mitochondria from MIP supernatant treated macrophages.
Cytoplasmic cytochrome c & AIF and also the nuclear
translocation of AIF were analyzed by western blot. Significantly
enhanced cytoplasmic expression of cytochrome c & AIF as well as
nuclear translocation of AIF was evident after 4 hr of treatment
(Fig. 3a). The fluorescence microscopy also demonstrated the
nuclear accumulation of AIF 4 hr post-treatment (Fig. 3b).
Figure 1. MIP supernatant induces apoptosis in mouse peritoneal macrophages. (a) MIP supernatant induced cell death of macrophages
was not due to LPS contamination. Macrophage monolayers were treated with MIP supernatant (1 mg/ml) for 8 hr and % cytotoxicity was determined
by MTT assay. Before incubation of macrophages with MIP supernatant, the supernatant was also treated either with Polymyxin B (PB). Untreated
cells were taken as control with 0% cytotoxicity. (b) Murine peritoneal macrophages after treatment with MIP supernatant for 4 hr were dual stained
with Sigma APOAC kit. Annexin V stained early apoptotic cells (annexin V positive, 6-CFDA positive) show red fluorescence on cell surface. Untreated
viable cells (annexin V negative, 6-CFDA positive) fluoresce green with no signal for Annexin V. (c) Macrophage monolayers were treated with MIP
supernatant for 6 hr, fixed & stained for DAPI. Arrows show nuclear condensation & fragmentation. Scale bar: 10 mm. (d) Macrophage monolayers
were treated with MIP supernatant for 6 hr, lysed and the DNA fragmentation was detected by quantitative Nucleosome ELISA with anti-histone
antibody. Untreated cells were taken as control. (e) MIP cell-free supernatant was lyophilized and re-suspended in sterile PBS & run on SDS-PAGE. The
gel was stained with AgNo3 and observed. Lane1: Low molecular weight SDS marker, lane2: MIP supernatant. The indicated molecular weights are in
kDa.
doi:10.1371/journal.pone.0017093.g001
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translocation to mitochondria
Activation of Bax and its mitochondrial translocation are the
key regulatory events during induction of mitochondrial mem-
brane depolarization and result into lowering of Dym. Treatment
of macrophages with MIP supernatant led to mitochondrial
translocation of Bax by as early as 1.5-2 hr of treatment. The
translocation of Bax-FITC (green fluorescence) to the mitochon-
dria (red fluorescence) is clearly demonstrated by co-localization of
green & red fluorescence. On the other hand, in untreated
macrophages the endogenous Bax was found diffused throughout
the cytoplasm (Fig. 4).
Inhibition of PKC inhibits MIP cell-free supernatant
induced apoptosis in macrophages
Pretreatment of macrophages with H7, a broad range inhibitor
of PKC and rottlerin, a pharmacological inhibitor of PKC d
inhibit MIP supernatant induced apoptosis significantly. Macro-
phages pretreated with H7 or rottlerin (10 mM) were incubated
with MIP supernatant for 8 hr and % cytotoxicity was measured;
H7 was found to inhibit apoptosis in as many as 60–70% of cells
while rottlerin rescued ,50% cells (Fig. 5a). Pretreatment of
macrophages with H7 also resulted into decreased caspase 3
activity (Fig. 5b).
Endogenous PKC d translocates to the nucleus after
treatment with MIP cell-free supernatant
PKC d plays a crucial role in apoptosis induced by agents that
target the mitochondria-dependent pathway and its nuclear
translocation has been implicated in the process. To determine
whether PKC d translocates to the nucleus in apoptotic cells,
nuclear and cytosolic fractions were separated and immunoblotted
for PKC d. Treatment with MIP supernatant led to a time
dependent nuclear translocation of PKC d (Fig. 5c).
MIP supernatant downregulates LPS induced
proinflammatory responses
LPS has been shown to induce higher level-expression of
proinflammatory cytokines in mouse peritoneal macrophages. The
effect of MIP supernatant on LPS induced proinflammatory
Figure 2. MIP supernatant induced caspase activation and PARP cleavage. (a) Measurement of cleaved (activated) caspase3 in Relative
Fluorescence Units (RFU) as a direct evidence for enhanced apoptosis of macrophages on treatment with MIP supernatant (60–100 ul/ml).
Macrophage monolayers were treated with different concentrations of MIP supernatant for 90 min & activated caspase3 was quantified using Sigma
caspase3 FL detection kit. (b) MIP supernatant induced caspase-3 activation and PARP degradation in peritoneal macrophages. Macrophage
monolayers were incubated with MIP supernatant (1 mg/ml) for 1, 2, 4 hr; the cells were harvested and examined by western blotting for procaspase-
3 (32 kDa) (upper panel), cleaved caspase-3 (p17) (middle panel) and PARP (116 kDa) degradation into the main proteolytic product of PARP (85 kDa).
Anti-actin Ab was used in parallel as a loading control (lower panels). Lane 1: Untreated control, 2: 1 hr, 3: 2 hr, 4: 4 hr. (c) Treatment of murine
peritoneal macrophages with MIP supernatant elicited disruption of mitochondrial trans-membrane potential. Mitochondrial membrane potential
was visualized with a MitoCapture Mitochondrial Apoptosis Detection kit. Pretreatment with pan-caspase inhibitor Z-VAD-fmk had no inhibitory
effect on MIP supernatant induced MMP. Staurosporin (S) (0.5 uM) treated cells were taken as a positive control. Bars in the figure show % of non-
apoptotic (red fluorescence) & apoptotic cells (Red & green fluorescence).
doi:10.1371/journal.pone.0017093.g002
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tant, LPS induced IL-b expression was markedly reduced by 12hrs
of treatment. MIP supernatant also led to an enhanced expression
of the Th2 cytokine IL-10 (Fig. 6).
Discussion
Mycobacterium indicus pranii (MIP) has been tested in a number of
disease models and its immunomodulatory properties in leprosy
are well documented [2–4,9]. The failure of BCG to protect
against the most prevalent form of tuberculosis, pulmonary TB,
has led to a heightened demand for more effective alternative
vaccine candidates. MIP has recently been evaluated where
vaccination with heat-killed MIP induces protection against TB in
animal models [5]. Currently, heat-killed MIP is commercially
available as a vaccine named ‘‘Immuvac’’.
We started our investigations with the aim to look for
immunomodulatory properties of heat-killed MIP using mouse
peritoneal macrophages. It was observed that the cell-free
supernatant collected from whole-cell MIP suspension induced
rapid and significant apoptosis in mouse peritoneal macrophages
in vitro. Apoptosis is generally characterized by early expression of
Phosphatidylserine on the cell surface, membrane blebbing,
nuclear condensation & DNA fragmentation, and thus detecting
the appearance of PS on the outer cell membrane is a sensitive
means to confirm the apoptotic mode of cell death. Staining of
MIP supernatant treated macrophages with annexin V-Cy3
confirmed that MIP supernatant induced cell death of macro-
phages is mediated through apoptosis. LPS contamination as the
suspected cause of cell death was experimentally excluded. MIP
supernatant consistently showed the presence of a protein band of
,46 kDa in SDS-PAGE. MALDI based analysis of this band
indicated a significant homology to peptide chain release factor of
bacterial origin. Peptide Chain Release Factor 1 carries an
Inhibitor of Apoptosis Protein (IAP) binding motif (IBM). IBM
containing proteins are thought to act as pro-apoptotic factors
which act by preventing repression or degradation of caspases and
are known to play role in mitochondria-mediated apoptosis. The
Figure 4. MIP supernatant induces Bax translocation to the mitochondria. Macrophage monolayers were treated with MIP supernatant for
1–1.5 hr and fixed. Cells were probed for Bax-FITC and Hoechst, mitochondria were stained red. The upper panel (A–E) shows untreated
macrophages while the lower panel (F–J) displays MIP supernatant treated macrophages. E and J show the overlay of respective panels. It is clear
from the overlay that there is distinct overlapping of red & green fluorescence indicating co-localization of Bax with mitochondria in the MIP
supernatant treated macrophages (J). Scale bar: 10 mm.
doi:10.1371/journal.pone.0017093.g004
Figure 3. MIP supernatant induced release of AIF and Cytochrome c into the cytoplasm, nuclear translocation of AIF. (a) Macrophage
monolayers were incubated with MIP supernatant for 3, 4 hr; the cytoplasmic and nuclear fractions were harvested and examined by western
blotting for AIF and cytochrome c. Lane 1: untreated cells, lane 2: 3 hr, lane 3: 4 hr. (b) Macrophage monolayers grown overnight on cover-glasses
were treated with MIP supernatant for 4 hr, washed & fixed with 4% paraformaldehyde, probed with anti-AIF-TRITC & Hoechst and visualized for
nuclear accumulation of AIF under Olympus BX61 fluorescence microscope. Upper panel: untreated, lower panel: MIP supernatant treated. The areas
encircled clearly demonstrate co-localization of a red signal for AIF in the nucleus in MIP supernatant treated macrophages. Scale bar: 10 mm.
doi:10.1371/journal.pone.0017093.g003
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potential of IAPs by directly binding to their BIR (Baculovirus
IAP Repeat) domain and thus until recently was thought to signify
as the core of their apoptogenic activity [17]. In all animal species,
apoptosis is linked to the activation of caspases, a class of cysteine
proteases that participates in the dismantling of essential cellular
components. Under these assumptions an IAP-binding protein
would, as a rule, act in a caspase dependent manner. Treatment of
macrophages with MIP supernatant agreeably resulted in
induction of caspase 3 activity, but pretreatment of macrophages
with pan-caspase inhibitor, Z-VAD-fmk failed to inhibit MIP
supernatant induced apoptosis. The caspase independent action of
the supernatant protein therefore, would refute the analogy
irrespective of its homology to an IAP-binding protein. To the
rescue is a recent demonstration that IAP-binding proteins may
not necessarily require an IBM for their apoptogenic potential and
therefore their apoptotic function is not mediated only through an
interaction with the IAPs [18]. This would mean that IAP binding
is a secondary function of these proteins and they may route
through other pathways of apoptosis induction where caspase
activity is only auxiliary to their apoptogenic potential. Caspase
independent nature of apoptosis in this case tempted us to look for
involvement of mitochondria in the process.
In mammals, apart from the classical receptor based activation,
caspases are also activated as the result of MMP, an event that
marks the point of no return in the death process [19]. The onset
of MMP is an abrupt event during apoptosis, leading to the release
of a number of apoptogenic proteins normally found in the space
between the inner and outer mitochondrial membranes (including
cytochrome c, AIF, and others) [20,21]. Depending upon the
initial cell death stimulus there are two different ways in which
caspases can contribute to cell death. First, the apoptotic signal
Figure 5. Involvement of PKC in MIP supernatant induced cell death of macrophages. (a) Macrophage monolayers were pretreated with
H7 or Rottlerin for 45 min, incubated with MIP supernatant for 8 hr and % cytotoxicity was determined by MTT assay. Untreated macrophages were
taken as control with 0% cytotoxicity. (b) Macrophages monolayers were pretreated with H7, incubated with different doses of MIP supernatant &
activated caspase 3 was quantified using caspase3 FL detection kit. Inhibiting PKC also resulted in decreased caspase 3 activities. RFU: Relative
Fluorescence Units. (c) MIP supernatant induced nuclear translocation of PKC d. Macrophage monolayers were treated with MIP supernatant for 1, 2
or 3 hr. Cytoplasmic and nuclear fractions were harvested and immunoblotted for PKC d. Lanes 1–4 (Cyto): control, 1 hr, 2 hr, 3 hr; lanes 5–8 (Nuc):
control, 1 hr, 2 hr, 3 hr. Cyto-cytoplasmic fraction, Nuc-nuclear fraction.
doi:10.1371/journal.pone.0017093.g005
Figure 6. MIP Supernatant resulted into downregulation of LPS
induced proinflammatory responses. Macrophage monolayers
were treated with LPS without or in the presence of 40 ul of MIP
supernatant for 12 hrs, supernatant was collected & ELISA was
performed for IL-1b & IL-10. Supernatant led to enhanced expression
of IL-10.
doi:10.1371/journal.pone.0017093.g006
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process. Alternatively, caspases can be activated at a later stage of
the process after MMP. In this case caspase activation appears to
constitute a sign rather than a mechanism of cell death and the
decisive event has occurred upstream or at the level of MMP,
though even later activation of caspase 3 can accelerate the
kinetics of apoptosis [19,22]. A significant population of MIP
supernatant treated macrophages showed decreased Dym by 4 hr
of treatment indicating MMP as the major factor regulating
supernatant induced apoptosis of macrophages. Apparently, in our
model caspase activation and mitochondrial alteration are either
mutually exclusive events or the activation of caspases is a post-
mitochondrial outcome.
Bcl-2 family member Bax has been shown to play a major role
in MMP. The mere addition of Bax to isolated mitochondria may
lead to release of pro-apoptotic proteins. Conversely, Bax deficient
cells may show complete resistance towards apoptotic stimuli
implicating Bax as one of the earliest determinants of cellular
apoptotic program. In most of the cells Bax is located
predominantly in the cytosol, but translocates to mitochondria at
an early stage in apoptosis [23,24]. During early hours of
supernatant treatment, a marked translocation of Bax onto the
mitochondria is observed. It is proposed that MIP supernatant
leads to translocation of cytoplasmic Bax to the mitochondria and
thus induces MMP. Furthermore, MIP supernatant induced MMP
and subsequent release of AIF and cytochrome c into the
cytoplasm and further translocation of AIF into the nucleus, as
observed, may be the key discrete events responsible for the
execution of programmed cell death of mouse peritoneal
macrophages. Experiments with pharmacological inhibitors re-
vealed that the supernatant induced Bax translocation and thus
MMP may be assisted by the members of PKC family as PKC
inhibitors inhibited macrophage apoptosis to a great extent in our
model. Recently the nuclear accumulation of PKC d has been
documented as a prerequisite for apoptosis in some cell types and
evidences suggest that nuclear PKC d regulates the cytosolic
apoptotic machinery acting as a regulator of mitochondria-
dependent apoptosis [25–28]. To look for this possibility, nuclear
and cytoplasmic fractions were harvested from MIP supernatant
treated macrophages and probed for the presence of PKC d.
Appreciable amount of nuclear PKC d was detected by as early as
2 hr of treatment. The kinetics of mitochondrial translocation of
Bax paralleled the nuclear translocation of PKC d suggesting some
kind of cooperativity between these two events, though it was hard
to find a direct relation. Moreover, a number of nuclear proteins
have been characterized to be substrates of PKC d in vitro [29]. We
report here that the novel protein kinase C isoform, PKC d,i s
required at or prior to the level of the mitochondria for MIP
supernatant induced apoptosis of macrophages. With AIF getting
translocated to the nucleus along with PKC d, MIP supernatant
probably activated two discrete, although seemingly dependent
mechanisms of apoptosis.
In recent times, there has been considerable interest in
understanding how microbial invasion may affect apoptosis of
eukaryotic cells and whether this contributes to pathogenesis. For
example, M. tuberculosis and other mycobacteria as well as a variety
of unrelated microbial pathogens have been reported to induce
apoptosis of host cells [30–32]. In some instances, apoptosis has
been observed to occur after infection of cells with viable
organisms and in other cases upon incubation of cells with
subcellular bacillary and secretory factors [33–37]. A repertoire of
mycobacterial products, including culture filtrate of M. tuberculosis,
supernatant from heat-treated mycobacteria, and purified protein
derivative have been shown to induce apoptosis. Apoptosis as a
phenomenon is associated with lack of inflammatory responses in
general but may also be associated with suppression of pro-
inflammatory cytokine production as in the case of Mycolactone, a
secretory product of Mycobacterium ulcerans [38]. Unlike washed
MIP cell pellet, sub-threshold doses of MIP supernatant led to a
significant downregulation of LPS induced expression of proin-
flammatory cytokine IL-1b. The observed drop in the levels of IL-
1b may be a direct consequence of the elevated levels of Th2
cytokine IL-10. Simultaneous treatment of peritoneal macrophag-
es with MIP supernatant led to increment in the expression of IL-
10 by several folds. The present study points toward the fact that
concomitant induction of IL-10 by MIP supernatant may
downsize the overall effective Th1 response generated by washed
MIP cell pellet. Furthermore, the apoptogenic property of MIP
supernatant may also account for some of the untoward effects of
the vaccine at the site of administration [2]. Under such conditions
the supernatant component of the original MIP suspension could
be a heavy compromise to the immunomodulatory potential of
heat-killed MIP as a vaccine. In the background of MIP
generating substantial success as a vaccine, not only prophylactic,
but also therapeutic, the current study may bear some critical
implications and needs immediate attention.
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